National Heart, Lung, and Blood Institute; Notice of Closed Meetings

Published date05 August 2019
Citation84 FR 38035
Record Number2019-16615
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 84 Issue 150 (Monday, August 5, 2019)
[Federal Register Volume 84, Number 150 (Monday, August 5, 2019)]
                [Notices]
                [Pages 38035-38036]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-16615]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Heart, Lung, and Blood Institute; Notice of Closed
                Meetings
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meetings.
                 The meetings will be closed to the public in accordance with the
                provisions set forth sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial
                [[Page 38036]]
                property such as patentable material, and personal information
                concerning individuals associated with the grant applications, the
                disclosure of which would constitute a clearly unwarranted invasion of
                personal privacy.
                 Name of Committee: National Heart, Lung, and Blood Institute
                Special Emphasis Panel; Opportunities for Collaborative Research at
                the NIH Clinical Center.
                 Date: September 4, 2019.
                 Time: 1:00 p.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: Office of Scientific Review/DERA, National Heart, Lung
                and Blood Institute, 6701 Rockledge Drive, Bethesda, MD 20879
                (Telephone Conference Call).
                 Contact Person: William J. Johnson, Ph.D., Scientific Review
                Officer, Office of Scientific Review/DERA, National Heart, Lung, and
                Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD
                20892-7924, 301-827-7938, [email protected].
                 Name of Committee: National Heart, Lung, and Blood Institute
                Special Emphasis Panel; Disparities Elimination through Coordinated
                Interventions to Prevent and Control Heart and Lung Disease Risk
                (DECIPHeR).
                 Date: September 13, 2019.
                 Time: 8:30 a.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: Residence Inn, Bethesda, 7335 Wisconsin Avenue, Bethesda,
                MD 20814.
                 Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
                Office of Scientific Review/DERA, National Heart, Lung, and Blood
                Institute, National Institutes of Health, 6701 Rockledge Drive, Room
                7185, Bethesda, MD 20892, 301-827-7953, [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.233,
                National Center for Sleep Disorders Research; 93.837, Heart and
                Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
                Blood Diseases and Resources Research, National Institutes of
                Health, HHS)
                 Dated: July 30, 2019.
                Ronald J. Livingston, Jr.,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2019-16615 Filed 8-2-19; 8:45 am]
                BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT